Related Experiment Videos
Left ventricular function after chronic insulin treatment in diabetic and normal rats
Journal of Molecular and Cellular Cardiology
|July 1, 1983
Summary
Insulin therapy can reverse streptozotocin-induced cardiomyopathy in rats, which is caused by insulin deficiency, not direct heart toxicity. Hyperinsulinemia also improves cardiac function.
Area of Science:
- Cardiology
- Endocrinology
- Diabetology
Background:
- Streptozotocin-induced diabetes in rats is associated with cardiomyopathy.
- The reversibility of this condition to insulin therapy requires investigation.
Purpose of the Study:
- To determine if insulin therapy can reverse streptozotocin-induced cardiomyopathy.
- To investigate the role of insulin deficiency versus direct cardiotoxicity in this condition.
Main Methods:
- Comparison of heart function in three groups of rats: untreated diabetic, insulin-treated diabetic, and control.
- Isolated working heart perfusion with measurement of cardiac performance indices.
- Assessment of Ca2+-actomyosin ATPase activity and myocardial relaxation times.
Main Results:
- Untreated diabetic rat hearts showed significant functional depressions compared to controls and insulin-treated rats.
- Insulin treatment reversed cardiomyopathy, with some indices suggesting overcorrection.
- Hyperinsulinemia in control rats improved cardiac function, indicating a beneficial effect of insulin.
Conclusions:
- Streptozotocin-induced cardiomyopathy is reversible with insulin therapy.
- The condition results from insulin deficiency, not a direct cardiotoxic effect of streptozotocin.
- Insulin therapy can improve myocardial function in diabetic cardiomyopathy.